<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39350799</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>The Use of Teledermatology for Skin Cancer Referrals: A Retrospective Study in a Single Tertiary Centre.</ArticleTitle><Pagination><StartPage>e68284</StartPage><MedlinePgn>e68284</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e68284</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.68284</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Teledermatology utilises telecommunications technology to deliver dermatological care remotely, incorporating live video consultations, store-and-forward systems, and hybrid approaches. It is particularly valuable in underserved or remote areas with limited access to dermatologists. Reported benefits include reduced face-to-face consultations for benign lesions, leading to increased capacity for severe cases, improved access for rural patients, and enhanced satisfaction among clinicians and patients. The COVID-19 pandemic accelerated the adoption of teledermatology, integrating it into the National Health Service (NHS) framework for managing referrals and ensuring continuity of care. This study examines the outcomes of two-week wait referrals for suspected skin cancer, focusing on diagnostic concordance between teledermatology and histopathology.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">The study was conducted at Addenbrooke's Hospital, part of Cambridge University Hospitals, via a retrospective review of patient records from November 2022 to May 2023. Inclusion criteria were all patients referred by their general practitioner (GP) under the two-week wait for suspected skin cancer pathway. Data collected included patient demographics, waiting times, clinical and histological diagnoses, and patient re-referrals for the same problem. The primary objective was to assess diagnostic concordance between the clinical diagnosis from teledermatology and histopathology. Secondary objectives included accuracy of lesion site description, patient waiting times, and computed time savings from the use of teledermatology.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The study covered 71 patients (34 males, 37 females) aged 19-87 years (mean: 59.63), with Fitzpatrick skin I-III predominating. A total of 110 individual lesions were assessed, and 46 required surgical management. Clinical and histological concordance was 62%, with 100% accuracy for basal cell carcinoma (BCC) and melanoma. The service saved 10 hours of consultant time and reduced the need for 62 initial face-to-face consultations. Lesion site documentation had a 73% correlation between GPs and dermatologists. Diagnoses varied widely between GPs and dermatologists, with a 31% concordance.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our study shows that teledermatology is a safe and effective method for managing two-week wait referrals for suspected skin cancer, reducing footfall, and saving time and costs for both clinicians and patients. While there are limitations, the usage of teledermatology allows increasingly limited capacity for face-to-face consultations to be reserved for high-risk patients. Further studies in different regions should explore teledermatology's utility across diverse demographics, particularly to address healthcare disparities for those with darker skin tones.</AbstractText><CopyrightInformation>Copyright © 2024, Sekaran et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sekaran</LastName><ForeName>Arvindh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Internal Medicine, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, GBR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vetsiou</LastName><ForeName>Evangelia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Dermatology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, GBR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Ashka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>General Medicine, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, GBR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khoo</LastName><ForeName>Andre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dermatology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, GBR.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">dermatology</Keyword><Keyword MajorTopicYN="N">diagnostic concordance</Keyword><Keyword MajorTopicYN="N">skin cancer</Keyword><Keyword MajorTopicYN="N">teledermatology</Keyword><Keyword MajorTopicYN="N">telemedicine</Keyword></KeywordList><CoiStatement>Human subjects: Consent was obtained or waived by all participants in this study. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>10</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>4</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39350799</ArticleId><ArticleId IdType="pmc">PMC11441827</ArticleId><ArticleId IdType="doi">10.7759/cureus.68284</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Clinical outcomes and operational impact of a medical photography based teledermatology service with over 8,000 patients in the UK. Palamaras I, Wark H, Short B, et al. J Vis Commun Med. 2022;45:6–17.</Citation><ArticleIdList><ArticleId IdType="pubmed">34854359</ArticleId></ArticleIdList></Reference><Reference><Citation>Patients' experiences of telemedicine for their skin problems: qualitative study. Chow A, Teo SH, Kong JW, Lee S, Heng YK, van Steensel M, Smith H. JMIR Dermatol. 2022;5:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10334905</ArticleId><ArticleId IdType="pubmed">37632855</ArticleId></ArticleIdList></Reference><Reference><Citation>Efficacy, perception, and utilization of pediatric teledermatology: a systematic review. Burshtein J, Buethe MG, Ghias MH, Stein AB, Glick S, Marmon S. JAAD Int. 2023;12:3–11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10203760</ArticleId><ArticleId IdType="pubmed">37228364</ArticleId></ArticleIdList></Reference><Reference><Citation>Store-and-forward teledermatology in a Spanish health area significantly increases access to dermatology expertise. Sánchez-Martín E, Moreno-Sánchez I, Morán-Sánchez M, Pérez-Martín M, Martín-Morales M, García-Ortiz L. BMC Prim Care. 2024;25:227.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11197177</ArticleId><ArticleId IdType="pubmed">38914974</ArticleId></ArticleIdList></Reference><Reference><Citation>Patient-led skin cancer teledermatology without dermoscopy during the COVID-19 pandemic: important lessons for the development of future patient-facing teledermatology and artificial intelligence-assisted -self-diagnosis. Ali OM, Wright B, Goodhead C, Hampton PJ. Clin Exp Dermatol. 2024;49:1056–1059.</Citation><ArticleIdList><ArticleId IdType="pubmed">38589979</ArticleId></ArticleIdList></Reference><Reference><Citation>A 14-year review of a UK teledermatology service: experience of over 40 000 teleconsultations. Mehrtens SH, Shall L, Halpern SM. Clin Exp Dermatol. 2019;44:874–881.</Citation><ArticleIdList><ArticleId IdType="pubmed">30767255</ArticleId></ArticleIdList></Reference><Reference><Citation>Teledermatology for the diagnosis and management of skin cancer: a systematic review. Finnane A, Dallest K, Janda M, Soyer HP. JAMA Dermatol. 2017;153:319–327.</Citation><ArticleIdList><ArticleId IdType="pubmed">27926766</ArticleId></ArticleIdList></Reference><Reference><Citation>The role of dermatopathology in conjunction with teledermatology in resource-limited settings: lessons from the African Teledermatology Project. Tsang MW, Kovarik CL. Int J Dermatol. 2011;50:150–156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3760682</ArticleId><ArticleId IdType="pubmed">21244377</ArticleId></ArticleIdList></Reference><Reference><Citation>Feasibility and diagnostic agreement in teledermatopathology using a virtual slide system. Massone C, Soyer HP, Lozzi GP, et al. Hum Pathol. 2007;38:546–554.</Citation><ArticleIdList><ArticleId IdType="pubmed">17270240</ArticleId></ArticleIdList></Reference><Reference><Citation>Teledermatology for diagnosis and management of skin conditions: a systematic review. Warshaw EM, Hillman YJ, Greer NL, Hagel EM, MacDonald R, Rutks IR, Wilt TJ. J Am Acad Dermatol. 2011;64:759–772.</Citation><ArticleIdList><ArticleId IdType="pubmed">21036419</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapid increase in telemental health within the Department of Veterans Affairs during the COVID-19 pandemic. Connolly SL, Stolzmann KL, Heyworth L, Weaver KR, Bauer MS, Miller CJ. Telemed J E Health. 2021;27:454–458.</Citation><ArticleIdList><ArticleId IdType="pubmed">32926664</ArticleId></ArticleIdList></Reference><Reference><Citation>A teledermatology roadmap: implementing safe and effective teledermatology triage pathways and processes.  [
Aug;
2024 
]. 2023. https://www.england.nhs.uk/long-read/a-teledermatology-roadmap-implementing-safe-and-effective-teledermatology-triage-pathways-and-processes/ https://www.england.nhs.uk/long-read/a-teledermatology-roadmap-implementing-safe-and-effective-teledermatology-triage-pathways-and-processes/</Citation></Reference><Reference><Citation>Impact of teledermatology on the accessibility and efficiency of dermatology care in an urban safety-net hospital: a pre-post analysis. Zakaria A, Maurer T, Su G, Amerson E. J Am Acad Dermatol. 2019;81:1446–1452.</Citation><ArticleIdList><ArticleId IdType="pubmed">31415834</ArticleId></ArticleIdList></Reference><Reference><Citation>Insights, advantages, and barriers of teledermatology vs. face-to-face dermatology for the diagnosis and follow-up of non-melanoma skin cancer: a systematic review. Nikolakis G, Vaiopoulos AG, Georgopoulos I, Papakonstantinou E, Gaitanis G, Zouboulis CC. Cancers (Basel) 2024;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10854718</ArticleId><ArticleId IdType="pubmed">38339329</ArticleId></ArticleIdList></Reference><Reference><Citation>Access to care.  [
Aug;
2024 
]. 2023. https://www.cqc.org.uk/publications/major-report/state-care/2022-2023/access-to-care https://www.cqc.org.uk/publications/major-report/state-care/2022-2023/access-to-care</Citation></Reference><Reference><Citation>Deep learning-aided decision support for diagnosis of skin disease across skin tones. Groh M, Badri O, Daneshjou R, et al. Nat Med. 2024;30:573–583.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10878981</ArticleId><ArticleId IdType="pubmed">38317019</ArticleId></ArticleIdList></Reference><Reference><Citation>Interobserver reliability of teledermatology across all Fitzpatrick skin types. Altieri L, Hu J, Nguyen A, et al. J Telemed Telecare. 2017;23:68–73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491917</ArticleId><ArticleId IdType="pubmed">26729754</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>